A Single-Dose Relative Bioavailability Study Of GBT440 300 mg Capsules in Healthy Subjects

Clinical trial NCT02567695 · COMPLETED

Trial details

NCT number: NCT02567695
Sponsor: Global Blood Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2015-09-01
Primary completion: 2016-06-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.